Becton, Dickinson and Company (BDX)
(Delayed Data from NYSE)
$176.37 USD
-1.88 (-1.05%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $176.31 -0.06 (-0.03%) 7:58 PM ET
4-Sell of 5 4
B Value D Growth C Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BDX 176.37 -1.88(-1.05%)
Will BDX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BDX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BDX
Earnings Preview: Becton Dickinson (BDX) Q3 Earnings Expected to Decline
Hologic's International Momentum Takes Shape: Will Execution Pay Off?
BDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
BD Partners With Waters to Build High-Volume Diagnostics Leader
How Hologic Leverages Its Financial Firepower to Drive Long-Term Value
Top Stock Reports for Amazon.com, Home Depot & Cisco Systems
Other News for BDX
Earnings week ahead: AMD, PLTR, PFE, DIS, O, ET, SHOP, GILD, MCD, CAT, VTRS, BP, UBER, CGC, and more
BDX Unveils At-Home HPV Test to Revolutionize Cervical Cancer Screening | BDX stock news
BD Aims to Save Lives by Empowering Women with Choice and Access to Cervical Cancer Screening ...
BDX Gains FDA Approval for BD Veritor System to Detect COVID-19 Antigens
BD gets FDA nod for rapid COVID-19 test